Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CLS vs GSK✓SelectedUSD · GSKCLS vs GSK performance historyLatest closeAs of+2.90%11/18
Stock and ETF performance explorer

CLS vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+2,028.8%
GSK return
+42.7%
Excess return
+1,986.1%
Maximum drawdown
-56.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+2.9%-1.3%+4.2%+2.9%
7D+0.2%-3.1%+3.3%+0.1%
30D-19.0%-0.9%-18.1%-19.0%
3M-21.7%-4.2%-17.5%-21.5%
6M-29.0%-1.6%-27.4%-29.1%
YTD-17.7%+2.6%-20.3%-17.9%
1Y-18.9%+6.2%-25.1%-19.3%
3Y+767.5%+55.0%+712.5%+691.4%
5Y+2,028.8%+42.8%+1,986.0%+1,723.8%
All+2,028.8%+42.7%+1,986.1%+1,723.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling